NGFR and neoplasm: We utilized flow cytometry in combination with lineage- and CD271-specific monoclonal antibodies to purify distinct CD271+ and CD271− tumor cell subsets from surgically removed, human tumor tissue specimens, described in detail9 (Fig. 1A).